The ART of HIV therapies: dopaminergic deficits and future treatments for HIV pediatric encephalopathy

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Expert Review of Anti-Infective Therapy

• Publication date

  2009-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1586/14787210.7.2.193PMID 19254168PMCID PMC3704143
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence of human immunodeficiency virus type 1 infection of nestin-positive neural progenitors in archival pediatric brain tissue

  2011cited by this paper
• Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: differential effects on behavior and the relationship to stereological hippocampal measures.

  2008cited by this paper
• Redefining the Role of Metallothionein within the Injured Brain

  2008cited by this paper
• Impact of the HIV/AIDS Epidemic on the Neurodevelopment of Preschool-Aged Children in Kinshasa, Democratic Republic of the Congo

  2008cited by this paper
• MRP (ABCC) Transporters-Mediated Efflux of Anti-HIV Drugs, Saquinavir and Zidovudine, from Human Endothelial Cells

  2008cited by this paper
• HIV/gp120 decreases adult neural progenitor cell proliferation via checkpoint kinase-mediated cell-cycle withdrawal and G1 arrest.

  2007cited by this paper
• Biomarkers, Laboratory, and Animal Models for the Design and Development of Adjunctive Therapies for HIV-1 Dementia and other Neuroinflammatory Disorders

  2007cited by this paper
• Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients

  2007cited by this paper
• Neurologic and neurodevelopmental manifestations of pediatric HIV/AIDS: a global perspective.

  2007cited by this paper
• Glycogen Synthase Kinase 3 Beta (GSK-3β) as a Therapeutic Target in NeuroAIDS

  2007cited by this paper
• Immunologic, Virologic, and Neuropsychologic Responses in Human Immunodeficiency Virus-Infected Children Receiving Their First Highly Active Antiretroviral Therapy Regimen

  2007cited by this paper
• Glycogen synthase kinase 3 beta (GSK-3 beta) as a therapeutic target in neuroAIDS.

  2007cited by this paper
• Neurotoxicity of HIV-1 Tat protein: involvement of D1 dopamine receptor.

  2007cited by this paper
• Neural progenitors and HIV-1-associated central nervous system disease in adults and children.

  2006cited by this paper
• Dopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1-infected brains

  2006cited by this paper
• An Examination of Executive Dysfunction Associated with Frontostriatal Circuitry in Parkinson's Disease

  2006cited by this paper
• Human immunodeficiency virus‐encoded Tat activates glycogen synthase kinase‐3β to antagonize nuclear factor‐κB survival pathway in neurons

  2006cited by this paper
• Mechanisms of neuronal injury and death in HIV-1 associated dementia.

  2006cited by this paper
• HIV-1 Tat neurotoxicity in primary cultures of rat midbrain fetal neurons: changes in dopamine transporter binding and immunoreactivity.

  2006cited by this paper
• Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3beta to antagonize nuclear factor-kappaB survival pathway in neurons.

  2006cited by this paper
• GATA‐3 regulates the transcriptional activity of tyrosine hydroxylase by interacting with CREB

  2006cited by this paper
• Valproic acid adjunctive therapy for HIV-associated cognitive impairment: A first report

  2006cited by this paper
• HIV-1 encephalopathy among perinatally infected children: Neuropathogenesis and response to highly active antiretroviral therapy.

  2006cited by this paper
• Effects of highly active antiretroviral therapy (HAART) on psychomotor performance in children with HIV disease

  2006cited by this paper
• Neurocognitive outcomes in pediatric HIV.

  2006cited by this paper
• Cognitive Functioning in School-Aged Children With Vertically Acquired HIV Infection Being Treated With Highly Active Antiretroviral Therapy (HAART)

  2006cited by this paper
• Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART).

  2005cited by this paper
• Neuroprotective and anti-human immunodeficiency virus activity of minocycline.

  2005cited by this paper
• Evaluation of neurodevelopmental deficits in children with HIV-1 infection.

  2005cited by this paper
• Quantitative Assessment of HIV-1 Protease Inhibitor Interactions with Drug Efflux Transporters in the Blood–Brain Barrier

  2005cited by this paper
• Neurocognitive functioning in pediatric human immunodeficiency virus infection: effects of combined therapy.

  2005cited by this paper
• Zinc Potentiates an Uncoupled Anion Conductance Associated with the Dopamine Transporter*

  2004cited by this paper
• HIV-1 promotes quiescence in human neural progenitor cells.

  2004cited by this paper
• Involvement of P-Glycoprotein in the Transport of Saquinavir and Indinavir in Rat Brain Microvessel Endothelial and Microglia Cell Lines

  2004cited by this paper
• Effects of Valproic Acid Coadministration on Plasma Efavirenz and Lopinavir Concentrations in Human Immunodeficiency Virus-Infected Adults

  2004cited by this paper
• Differential regulation of metallothionein-I and metallothionein-II mRNA expression in the rat brain following traumatic brain injury.

  2004cited by this paper
• Child mortality and HIV infection in Africa: a review

  2004cited by this paper
• DSM-IV mental disorders and neurological complications in children and adolescents with human immunodeficiency virus type 1 infection (HIV-1)

  2004cited by this paper
• Hemophilia Growth and Development Study: caregiver report of youth and family adjustment to HIV disease and immunologic compromise.

  2003cited by this paper
• High rates of behavioral problems in perinatally HIV-infected children are not linked to HIV disease.

  2003cited by this paper
• Regulation of tissue inhibitor of metalloproteinase‐1 by astrocytes: Links to HIV‐1 dementia

  2003cited by this paper
• Neuroprotective Activities of Sodium Valproate in a Murine Model of Human Immunodeficiency Virus-1 Encephalitis

  2003cited by this paper
• Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum.

  2003cited by this paper
• HIV-1 infection and AIDS.

  2002cited by this paper
• Cognitive Development in School-Age Children With Vertically Transmitted HIV Infection

  2002cited by this paper
• Effect of combination antiretroviral therapy on cerebrospinal fluid HIV RNA, HIV resistance, and clinical manifestations of encephalopathy.

  2002cited by this paper
• Cognitive and motor development in children with vertically transmitted HIV infection.

  2001cited by this paper
• Dopamine receptor regulating factor, DRRF: A zinc finger transcription factor

  2001cited by this paper
• An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction

  2001cited by this paper
• School-Age Children with Perinatally Acquired HIV Infection: Medical and Psychosocial Issues in a Philadelphia Cohort

  2001cited by this paper
• Roles of the metallothionein family of proteins in the central nervous system.

  2001cited by this paper
• [Development of the nervous system].

  2000cited by this paper
• Mononuclear phagocytes mediate blood‐brain barrier compromise and neuronal injury during HIV‐1‐associated dementia

  2000cited by this paper
• HIV Infection and Dementia

  2000cited by this paper
• Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival.

  2000cited by this paper
• In vitro neurogenesis by progenitor cells isolated from the adult human hippocampus

  2000cited by this paper
• Declining immune function in children and adolescents with hemophilia and HIV infection: effects on neuropsychological performance. Hemophilia Growth and Development Study.

  2000cited by this paper
• Dopamine systems in human immunodeficiency virus-associated dementia.

  1999cited by this paper
• HIV‐1 Tat‐Mediated Activation of Glycogen Synthase Kinase‐3β Contributes to Tat‐Mediated Neurotoxicity

  1999cited by this paper
• Working memory, short-term memory, and general fluid intelligence: a latent-variable approach.

  1999influential reference
• Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals.

  1999cited by this paper
• High Viral Load in the Cerebrospinal Fluid and Brain Correlates with Severity of Simian Immunodeficiency Virus Encephalitis

  1999cited by this paper
• Distribution of Brain HIV Load in AIDS

  1998cited by this paper
• [Antiretroviral therapy in children].

  1998cited by this paper
• Receptive and expressive language function of children with symptomatic HIV infection and relationship with disease parameters: a longitudinal 24‐month follow‐up study

  1997cited by this paper
• Neurological and developmental problems in pediatric HIV infection.

  1996cited by this paper
• Impairment of expressive behavior in pediatric HIV-infected patients with evidence of CNS disease.

  1996cited by this paper
• Levodopa therapy improves motor function in HIV-infected children with extrapyramidal syndromes

  1996cited by this paper
• HIV‐1 encephalopathy in children

  1995cited by this paper
• Encephalopathy in children with perinatally acquired human immunodeficiency virus infection. Pediatric Spectrum of Disease Clinical Consortium.

  1995cited by this paper
• Differential receptive and expressive language functioning of children with symptomatic HIV disease and relation to CT scan brain abnormalities.

  1995cited by this paper
• Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin

  1994cited by this paper
• Psychiatric morbidity in school-age children with congenital human immunodeficiency virus infection: a pilot study.

  1994cited by this paper
• Human immunodeficiency virus type 1 infection of the nervous system: Pathogenetic mechanisms

  1993cited by this paper
• Cognitive and motor impairments associated with SIV infection in rhesus monkeys.

  1992cited by this paper
• Excitotoxicity and dopaminergic dysfunction in the acquired immunodeficiency syndrome dementia complex. Therapeutic implications.

  1991cited by this paper
• The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex.

  1988cited by this paper
• Neurological and neuropathological features of human immunodeficiency virus infection in children

  1988cited by this paper
• Brain pathology induced by infection with the human immunodeficiency virus (HIV)

  1987cited by this paper
• Acquired immunodeficiency syndrome in children: report of the Centers for Disease Control National Surveillance, 1982 to 1985.

  1987cited by this paper
• Neurologic manifestations of human immunodeficiency virus infection in children.

  1986cited by this paper
• Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy.

  1986cited by this paper
• Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

  1983cited by this paper
• [Blood-brain barrier: its structure and function].

  1973cited by this paper

• Bioenergetic adaptations to HIV infection. Could modulation of energy substrate utilization improve brain health in people living with HIV-1?

  2020cites this paper
• Dopamine increases HIV entry into macrophages by increasing calcium release via an alternative signaling pathway.

  2019cites this paper
• Global developments in HIV neurology.

  2018cites this paper
• Dose‐dependent neurocognitive deficits following postnatal day 10 HIV‐1 viral protein exposure: Relationship to hippocampal anatomy parameters

  2018influential citation
• Novel use of levodopa in human immunodeficiency virus encephalopathy-mediated parkinsonism in an adult

  2018cites this paper
• Brain Aging in HIV-1 Infection

  2018cites this paper
• Cognitive Function in Young Persons With and Without Perinatal HIV in the AALPHI Cohort in England: Role of Non-HIV-Related Factors.

  2016cites this paper
• HIV-1 proteins, Tat and gp120, target the developing dopamine system.

  2015cites this paper
• Blood-brain barrier and neuro-AIDS.

  2015cites this paper
• Evidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat

  2010cites this paper